Stay updated on ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer

Sign up to get notified when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.
Latest website image capture
Clouds background image

Latest updates to the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new version of the prostate cancer trial record was submitted on November 3, 2026, with a change to the study status. The history also reflects a date adjustment for an earlier version.
    Difference
    0.1%
    Check dated 2026-11-08T06:14:18.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-01T04:00:11.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.2%
    Check dated 2026-10-25T04:48:36.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-18T04:01:46.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-11T08:19:07.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a new Study Status entry to the study's record history on 2026-09-25, with a cross-reference to 2026-09-24 and the number 122. This documents an update to the study's current status within the history log.
    Difference
    0.1%
    Check dated 2026-09-27T07:55:16.000Z thumbnail image

Stay in the know with updates to ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer

Enter your email address, and we'll notify you when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.